EMSLIMITED Share Price Target 2035

CAGR-based price projection for EMS Limited (EMSLIMITED) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (2.7% CAGR)
Rs 423
2035 Target
Base Case (6.9% CAGR)
Rs 603
2035 Target
Bull Case (18.5% CAGR)
Rs 1,523
2035 Target

Current Market Snapshot

CMP: Rs 331.55
52W High: Rs 458.15
52W Low: Rs 290.85
1Y CAGR: 14.2%
3Y CAGR: 6.9%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 341 Rs 354 Rs 393
2028 Rs 350 Rs 379 Rs 465
2029 Rs 360 Rs 405 Rs 551
2030 Rs 369 Rs 432 Rs 653
2031 Rs 380 Rs 462 Rs 773
2032 Rs 390 Rs 494 Rs 916
2033 Rs 401 Rs 528 Rs 1,085
2034 Rs 412 Rs 564 Rs 1,286
2035 Rs 423 Rs 603 Rs 1,523

Other EMSLIMITED Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the EMSLIMITED share price target for 2035?

Based on historical growth analysis, the EMSLIMITED share price target for 2035 ranges from Rs 423 (conservative) to Rs 603 (base case) to Rs 1,523 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of EMSLIMITED?

The current market price of EMSLIMITED (EMS Limited) is Rs 331.55. The 52-week high is Rs 458.15 and 52-week low is Rs 290.85.

Is EMSLIMITED a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for EMSLIMITED price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 2.7% CAGR), Base (6.9% CAGR), and Bull (optimistic at 18.5% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.